Does ENCORAFENIB Cause Intestinal perforation? 19 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 19 reports of Intestinal perforation have been filed in association with ENCORAFENIB (BRAFTOVI). This represents 0.2% of all adverse event reports for ENCORAFENIB.
19
Reports of Intestinal perforation with ENCORAFENIB
0.2%
of all ENCORAFENIB reports
5
Deaths
14
Hospitalizations
How Dangerous Is Intestinal perforation From ENCORAFENIB?
Of the 19 reports, 5 (26.3%) resulted in death, 14 (73.7%) required hospitalization, and 2 (10.5%) were considered life-threatening.
Is Intestinal perforation Listed in the Official Label?
Yes, Intestinal perforation is listed as a known adverse reaction in the official FDA drug label for ENCORAFENIB.
What Other Side Effects Does ENCORAFENIB Cause?
Death (1,004)
Off label use (989)
Nausea (758)
Fatigue (685)
Diarrhoea (574)
Neoplasm progression (548)
Pyrexia (539)
Product use in unapproved indication (506)
Vomiting (429)
Rash (414)
What Other Drugs Cause Intestinal perforation?
ADALIMUMAB (1,010)
BEVACIZUMAB (600)
RITUXIMAB (321)
TOCILIZUMAB (276)
PREDNISONE (266)
CYCLOPHOSPHAMIDE (262)
DOXORUBICIN (240)
LENVATINIB (228)
INFLIXIMAB (226)
PEMBROLIZUMAB (220)
Which ENCORAFENIB Alternatives Have Lower Intestinal perforation Risk?
ENCORAFENIB vs ENDOXAN
ENCORAFENIB vs ENDOXAN BAXTER
ENCORAFENIB vs ENDOXAN INJ
ENCORAFENIB vs ENDOXAN , POUDRE POUR
ENCORAFENIB vs ENFORTUMAB VEDOTIN